The protective effects of Telmisartan on the cardiovascular system
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-C000000331
- Lead Sponsor
- Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
*Secondary hypertension *heart failure *diabetes mellitus *acute myocardial infarction within 6 months *treated with PCI within 6 months *cerebrovascular disease within 3 months *severe renal failure (serum creatinine>3mg/dl *severe hepatic failure *malignant disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood pressure, cardiovascular clinical event,cardiac hypertrophy, cardiac function, atherosclerosis,insulin resistance, renal function
- Secondary Outcome Measures
Name Time Method